Table 1.

GPIIIa immunodominant peptides. Peptides, previously reported to contain Th epitopes that are immunodominant in patients with immune thrombocytopenia,7 were manufactured to their wild-type sequence or extended using an arginine-lysine wrapper to improve manufacturability and solubility.

Table 1.